priority reviews in ovarian cancer, prostate cancer, nsclc, and more
Published 4 years ago • 125 plays • Length 10:04
Download video MP4
Download video MP3
Similar videos
-
5:35
priority reviews in breast cancer and nsclc, promising results in ovarian cancer, and more
-
6:24
fda approval and priority review in ovarian cancer, end of part b payment model, and more
-
0:31
preview: fda approval and priority review in ovarian cancer, end of part b payment model, and more
-
5:27
priority review in ovarian cancer, rolling submission in alk-positive nsclc, and more
-
10:25
priority reviews in prostate and bladder cancer, nccn crc guidelines update, and more
-
0:31
preview: priority reviews in breast cancer and nsclc, promising results in ovarian cancer, and more
-
7:19
fda approval in hcc, priority reviews in tnbc and ovarian cancer, snda in itp, and more
-
6:17
staging intermediate- and high-risk prostate cancer with 18f psma/pet/ct vs mri
-
7:18
priority review in lung cancer, nda in ovarian cancer, promising results in myeloma, and more
-
12:17
fda approvals in breast cancer and prostate cancer, priority review in breast cancer, and more
-
12:40
fda approval in aml, priority review in prostate cancer, ema chmp recommendations, and more
-
7:27
fda approvals in prostate cancer and endometrial cancer, and priority review in urothelial cancer
-
9:08
fda approvals in cervical cancer, ovarian cancer, and cll, and more
-
10:11
priority review designation in cervical cancer, odac recommendation in all, and more
-
8:10
priority review designation in nsclc, fast track designation in aml, and crl issued for a biosimilar
-
3:30
2020 in review: olaparib & rucaparib, fda approval | ask a prostate expert, mark scholz, md
-
6:10
ovarian cancer: updates to nccn guidelines
-
4:29
case review: ovarian cancer and the initial treatment options
-
5:15
rucaparib and olaparib: two new treatments approved for advanced prostate cancer | pcri
Clip.africa.com - Privacy-policy